In general agreement with these epidemiological findings, our data from the mouse model of Down syndrome show that the mortality rate for COVID-19 was ≈11-fold higher by day 6 p.i in Dp16;ACE2 mice (31.3%) than in ACE2 littermates (2.8%) (Figure 1C). Here, ACE2 is linked to Down syndrome.